DK49283A - Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler - Google Patents

Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler Download PDF

Info

Publication number
DK49283A
DK49283A DK49283A DK49283A DK49283A DK 49283 A DK49283 A DK 49283A DK 49283 A DK49283 A DK 49283A DK 49283 A DK49283 A DK 49283A DK 49283 A DK49283 A DK 49283A
Authority
DK
Denmark
Prior art keywords
pyrazoloxazines
thiazines
quinolines
medicines
preparing
Prior art date
Application number
DK49283A
Other languages
Danish (da)
English (en)
Other versions
DK49283D0 (da
Inventor
Mithat Mardin
Rudolf Sundermann
Friedrich Hoffmeister
Wolf-Dieter Busse
Harald Horstmann
Siefried Raddatz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK49283D0 publication Critical patent/DK49283D0/da
Publication of DK49283A publication Critical patent/DK49283A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK49283A 1982-02-06 1983-02-04 Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler DK49283A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK49283D0 DK49283D0 (da) 1983-02-04
DK49283A true DK49283A (da) 1983-08-07

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK49283A DK49283A (da) 1982-02-06 1983-02-04 Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler

Country Status (16)

Country Link
US (1) US4552874A (cs)
EP (1) EP0085881A3 (cs)
JP (1) JPS58146583A (cs)
KR (1) KR840003641A (cs)
AU (1) AU1112583A (cs)
DE (1) DE3204126A1 (cs)
DK (1) DK49283A (cs)
ES (1) ES519559A0 (cs)
FI (1) FI830378A7 (cs)
GR (1) GR77960B (cs)
HU (1) HU190063B (cs)
IE (1) IE830227L (cs)
IL (1) IL67826A0 (cs)
NO (1) NO830236L (cs)
PT (1) PT76147A (cs)
ZA (1) ZA83743B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
ES537162A0 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
EP0913395A1 (en) * 1995-12-08 1999-05-06 Ube Industries, Ltd. N-phenylcarbamate compounds, process for producing the same, and agricultural or horticultural bactericides
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
BRPI0414856A (pt) 2003-10-03 2006-11-21 3M Innovative Properties Co imidazoquinolinas alcóxi-substituìdas
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
NZ547467A (en) 2003-11-25 2010-06-25 3M Innovative Properties Co Substituted imidazo ring system and methods
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
EP1831226B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US7968563B2 (en) 2005-02-11 2011-06-28 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
JP2010529145A (ja) * 2007-06-08 2010-08-26 ヘリコン・セラピューティクス・インコーポレーテッド 治療用ピラゾロナフチリジン誘導体
US7872002B2 (en) * 2007-06-08 2011-01-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline derivatives
CA2688405A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
ES8402591A1 (es) 1984-02-01
NO830236L (no) 1983-08-08
IE830227L (en) 1983-08-06
AU1112583A (en) 1983-08-11
DE3204126A1 (de) 1983-08-11
IL67826A0 (en) 1983-06-15
EP0085881A2 (de) 1983-08-17
ZA83743B (en) 1983-11-30
PT76147A (en) 1983-02-01
ES519559A0 (es) 1984-02-01
KR840003641A (ko) 1984-09-15
US4552874A (en) 1985-11-12
EP0085881A3 (de) 1984-03-07
HU190063B (en) 1986-08-28
FI830378L (fi) 1983-08-07
GR77960B (cs) 1984-09-25
FI830378A7 (fi) 1983-08-07
DK49283D0 (da) 1983-02-04
FI830378A0 (fi) 1983-02-03
JPS58146583A (ja) 1983-09-01

Similar Documents

Publication Publication Date Title
DK49283A (da) Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK310383A (da) 14-fluormorphinaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK675787A (da) 8-substituerede 2-aminotetraliner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK165249C (da) Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK398583A (da) Spergualin-beslaegtede forbindelser, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK16982A (da) Sisomicin-derivater fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemidler
DK382283A (da) Thiazol-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK166210C (da) Krystallinske cephalosporin-hydrohalogenidsalte, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK544383D0 (da) Svovlholdige benzylidenderivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK442183D0 (da) Thiatriazin-derivater, fremgangsmader til fremstilling deraf og deres anvendelse som laegemidler
DK548086D0 (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK100081A (da) Quinolinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK540887D0 (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK329882A (da) Oxothienobenzoxepiner,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK260884D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK134083D0 (da) 7-alfa-aminoacyl-3-chlorcephalosporiner, fremgangsmade til deres fremstilling samt deres anvendelse som laegemidler
DK30186A (da) (1,2,4-oxadiazol-3-yl)-arylmethanoner, fremgangsmaade til fremstilling heraf samt deres anvendelse som medikamenter
DK508482A (da) Diphenylethere, fremgangsmaade til deres fremstilling samt deres anvendelse
DK368483D0 (da) Imidazolderivater eller salte deraf, fremgangsmade til deres fremstilling samt deres anvendelse
DK84684A (da) Svovlholdige benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK544283D0 (da) Alkylerede benzylidenderivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK321387D0 (da) Cytorhodin s-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
ATS Application withdrawn